178 related articles for article (PubMed ID: 2502833)
21. [Complement deficiencies and meningococcal disease in The Netherlands].
Swart AG; Fijen CA; te Bulte MT; Daha MR; Dankert J; Kuijper EJ
Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1147-52. PubMed ID: 8316311
[TBL] [Abstract][Full Text] [Related]
22. Fulminant meningococcal infections in a family with inherited deficiency of properdin.
Braconier JH; Sjöholm AG; Söderström C
Scand J Infect Dis; 1983; 15(4):339-45. PubMed ID: 6658381
[TBL] [Abstract][Full Text] [Related]
23. Salivary and Serum Antibody Response Against Neisseria meningitidis After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers.
Bårnes GK; Workalemahu B; Kristiansen PA; Beyene D; Merdekios B; Fissiha P; Aseffa A; Caugant DA; Naess LM
Scand J Immunol; 2016 Aug; 84(2):118-29. PubMed ID: 27219622
[TBL] [Abstract][Full Text] [Related]
24. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
[TBL] [Abstract][Full Text] [Related]
25. Low prevalence of complement deficiencies among patients with meningococcal disease in Norway.
Høgåsen K; Michaelsen T; Mellbye OJ; Bjune G
Scand J Immunol; 1993 Apr; 37(4):487-9. PubMed ID: 8469932
[TBL] [Abstract][Full Text] [Related]
26. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
[TBL] [Abstract][Full Text] [Related]
27. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
[TBL] [Abstract][Full Text] [Related]
28. Fulminant meningococcal septic shock in a boy with combined inherited properdin and protein C deficiency.
Fijen CA; Derkx BH; Kuijper EJ; Mannens M; Poort SR; Peters M; Daha MR; Dankert J
Clin Exp Immunol; 1995 Nov; 102(2):290-6. PubMed ID: 7586681
[TBL] [Abstract][Full Text] [Related]
29. The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine.
Dbaibo G; Van der Wielen M; Reda M; Medlej F; Tabet C; Boutriau D; Sumbul A; Anis S; Miller JM
Int J Infect Dis; 2012 Aug; 16(8):e608-15. PubMed ID: 22704725
[TBL] [Abstract][Full Text] [Related]
30. Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy.
D'Amelio R; Agostoni A; Biselli R; Brai M; Caruso G; Cicardi M; Corvetta A; Fontana L; Misiano G; Perricone R
Scand J Immunol; 1992 May; 35(5):589-95. PubMed ID: 1579859
[TBL] [Abstract][Full Text] [Related]
31. An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.
Norheim G; Tunheim G; Næss LM; Kristiansen PA; Caugant DA; Rosenqvist E
Scand J Immunol; 2012 Aug; 76(2):99-107. PubMed ID: 22537024
[TBL] [Abstract][Full Text] [Related]
32. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
[TBL] [Abstract][Full Text] [Related]
33. Inherited complement deficiency in children surviving fulminant meningococcal septic shock.
Derkx HH; Kuijper EJ; Fijen CA; Jak M; Dankert J; van Deventer SJ
Eur J Pediatr; 1995 Sep; 154(9):735-8. PubMed ID: 8582425
[TBL] [Abstract][Full Text] [Related]
34. Meningococcal vaccines.
Price AA
Curr Pharm Des; 2007; 13(19):2009-14. PubMed ID: 17627534
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.
Ladhani SN; Giuliani MM; Biolchi A; Pizza M; Beebeejaun K; Lucidarme J; Findlow J; Ramsay ME; Borrow R
Emerg Infect Dis; 2016 Feb; 22(2):309-11. PubMed ID: 26811872
[TBL] [Abstract][Full Text] [Related]
36. Serum bactericidal activity and induction of chemiluminescence of polymorphonuclear leukocytes: complement activation pathway requirements in defense against Neisseria meningitidis.
Fredlund H; Sjöholm AG; Selander B; Holmström E; Olcén P; Danielsson D
Int Arch Allergy Immunol; 1993; 100(2):135-43. PubMed ID: 8443467
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.
Morley SL; Cole MJ; Ison CA; Camaraza MA; Sotolongo F; Anwar N; Cuevas I; Carbonero M; Campa HC; Sierra G; Levin M
Pediatr Infect Dis J; 2001 Nov; 20(11):1054-61. PubMed ID: 11734711
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
Ambrosch F; Wiedermann G; Crooy P; George AM
Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
[TBL] [Abstract][Full Text] [Related]
39. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.
Naess LM; Aarvak T; Aase A; Oftung F; Høiby EA; Sandin R; Michaelsen TE
Vaccine; 1999 Feb; 17(7-8):754-64. PubMed ID: 10067680
[TBL] [Abstract][Full Text] [Related]
40. Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis.
Lim D; Gewurz A; Lint TF; Ghaze M; Sepheri B; Gewurz H
J Pediatr; 1976 Jul; 89(1):42-7. PubMed ID: 819642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
